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Available online 11 August 2016The schizophrenia prodrome has not been extensively studied in Africa. Identiﬁcation of prodromal behavioral
symptoms holds promise for early intervention and prevention of disorder onset. Our goal was to investigate
schizophrenia risk traits in Kenyan adolescents and identify predictors of psychosis progression.
135 high-risk (HR) and 142 low-risk (LR) adolescents were identiﬁed from among secondary school students in
Machakos, Kenya, using the structured interview of psychosis-risk syndromes (SIPS) and the Washington early
recognition center affectivity and psychosis (WERCAP) screen. Clinical characteristics were compared across
groups, and participants followed longitudinally over 0-, 4-, 7-, 14- and 20-months. Potential predictors of psy-
chosis conversion and severity change were studied using multiple regression analyses.
More psychiatric comorbidities and increased psychosocial stress were observed in HR compared to LR partici-
pants. HR participants also had worse attention and better abstraction. The psychosis conversion rate was 3.8%,
with only disorganized communication severity at baseline predicting conversion (p = 0.007). Decreasing psy-
chotic symptom severity over the study period was observed in both HR and LR participants. ADHD, bipolar dis-
order, and major depression diagnoses, as well as poor occupational functioning and avolition were factors
relating to lesser improvement in psychosis severity.
Our results indicate that psychopathology and disability occur at relatively high rates in Kenyan HR adolescents.
Few psychosis conversions may reﬂect an inadequate time to conversion, warranting longer follow-up studies to
clarify risk predictors. Identifying disorganized communication and other risk factors could be useful for develop-
ing preventive strategies for HR youth in Kenya.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
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Risk1. Introduction
The onset of schizophrenia typically occurs during late adolescence
or early adulthood (Jablensky et al., 1992; Kirkbride et al., 2006), a crit-
ical period of development during which young people are usually
going through school and are becoming independent from their par-
ents. Understanding how psychosis presents across cultures is crucial
to both elucidating etiological process and improving treatment. How-
ever, there is relatively little information about psychotic disorders in
the developingworld (Saxena et al., 2006), and in particular, few epide-
miologic studies of psychosis development in Africa (Guinness, 1992;Washington University Medical
s.
amah).
. This is an open access article underSaha et al., 2005). The need for more studies is underscored by existing
data, which suggests that there are differences in the presentation and
course of psychotic disorders in Africa compared to developed countries
(German, 1972; Guinness, 1992). For example, delusional content often
reﬂects the prevalent cultural beliefs, with themes of witchcraft or an-
cestral worship more commonly experienced in Africa (Hurst, 1975).
Also, existing studies suggest thatwhile the prevalence of schizophrenia
is comparable across the world, the course and outcome is often more
severe in the developed world than in developing countries (Hopper
and Wanderling, 2000; Kulhara, 1994; Sartorius et al., 1986).
In recent years, there has been a growing recognition of the need to
develop pre-emptive strategies for schizophrenia that derail progres-
sion toward independence and productivity. In sub-Saharan Africa,
where ﬁnancial and health care resources formanaging psychotic disor-
ders are extremely limited, the role of early intervention strategies priorthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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risk (CHR) criteria for developingpsychotic disorder, comprised primar-
ily of attenuated psychotic symptoms, aim to identify the prodromal
stage of schizophrenia (Cannon et al., 2008). Studies indicate that 16%
to 54% of youth who meet current clinical risk criteria develop a major
psychotic disorder within 1–2.5 years (Cannon et al., 2008; Ruhrmann
et al., 2010; Schultze-Lutter et al., 2015; Yung et al., 2008). Major global
research efforts involving CHR include the North American Prodrome
Longitudinal Study (NAPLS), the European Prediction of Psychosis
Study (EPOS), and the Personal Assessment and Crisis Evaluation
(PACE) clinic in Melbourne Australia. The NAPLS study, which com-
prises of the largest database on prospectively followed prodromal
cases worldwide previously found ﬁve features that contributed
uniquely to the prediction of psychosis: familial risk with functional de-
cline, unusual thought content, paranoia, low social functioning, and
substance abuse (Cannon et al., 2008). These predictors had a substan-
tial, but not complete, overlap with predictors found in related studies
(Addington et al., 2015; Thompson et al., 2011). Based on identiﬁed pre-
dictors from existing studies, an individualized risk calculator for psy-
chosis conversion has also been proposed (Schultze-Lutter et al., 2015).
To our knowledge, our group was the ﬁrst to investigate the CHR
state in Africa andwehavemaintained an active research programchar-
acterizing psychosis-risk traits in Kenyan youths. Our previous investi-
gations using various psychosis-risk screening instruments showed
relatively high rates of psychotic experiences in Kenyan children
(Mamah et al., 2013a), adolescents (Mamah et al., 2013a) and young
adults (Mamah et al., 2012; Ndetei et al., 2012) in school and communi-
ty settings. These ﬁndings may have overestimated psychotic experi-
ence prevalence rates, as these were higher than those observed in
some studies done in developed countries (e.g. (Gale et al., 2011;
Kelleher et al., 2012; Mojtabai, 2006)). Large variations in prevalence
rates have been reported globally (Nuevo et al., 2012), which suggests
that assessment toolsmay not always be cross-culturally applicable. Re-
sults of our previous studies as well as information gathered from focus
groups (Mamah et al., 2013b) contributed to our development of cultur-
ally-sensitive research tools to better characterize the CHR state in
Kenya. The current study is the most extensive investigation of psycho-
sis-risk individuals in Africa, incorporating multiple behavioral assess-
ments in an adolescent population and including longitudinal
investigations of at-risk individuals for the ﬁrst time in the continent.
2. Methods
2.1. Recruitment
The study was approved by the ethical review board of the Kenya
Medical Research Institute and the Institutional Review Board of
Washington University in St. Louis. Participants were students from
22 secondary schools in Machakos county, Kenya, a largely rural area
near Nairobi. Participants were selected from among 2800 students in
the 10th–12th grades of study, aged 14–20 years, who completed the
Washington Early Recognition Center Affectivity and Psychosis
(WERCAP) Screen (Mamah et al., 2014). The selection process is sum-
marized in Fig. 1. As a preliminary selection process, screened subjects
were divided into those at preliminary high-risk (HR) and those at pre-
liminary low-risk (LR) based onWERCAP psychosis-risk scores (i.e. ≥30
and b30 respectively) (Mamah et al., 2014). Based on preliminarily
assigned risk status, 330 individuals were enrolled in the study. Deter-
mination of ﬁnal risk status was done as described below. Written
consent was provided by a parent or guardian or by the student if
aged 18 or older.
2.2. Inclusion and exclusion criteria
Participants were excluded from the HR or LR groups if they
met criteria for current or lifetime Axis I psychotic disorder. Participantsin the HR groups met diagnostic criteria for a prodromal syndrome
using the Structured Interview for Psychosis-Risk Syndromes (SIPS)
(McGlashan et al., 2010) or the WERCAP Screen criteria (Mamah et al.,
2014). The decision to use both structured and self-report measures to
estimate risk state capitalizes on the strengths of each assessment
format in obtaining behavioral data. Structured assessments alone can
be inﬂuenced by perceived stigma and rater characteristics, while self-
report questionnairesmaynot be adequately understood by the respon-
dent (Mamah et al., 2014).
2.3. Clinical assessments and core evaluations
Psychosis-risk symptomswere assessed using the positive symptom
subscale of the SIPS and theWERCAP Screen. The SIPS is a structured in-
terview that includes ﬁve positive symptom subscales: P1-unusual
thought content/delusional ideas, P2-suspiciousness/persecutory
ideas, P3-grandiose ideas, P4-perceptual abnormalities, and P5-disorga-
nization communication. Positive symptoms are rated from 0 (absent)
to 6 (severe/psychotic). In addition to the positive symptom subscale,
the SIPS contains three additional subscales that were also assessed:
negative, disorganization and general symptoms. The WERCAP Screen
estimates the severity of psychotic symptoms and “affectivity”, a mea-
sure of mood dysregulation (Mamah et al., 2014). Psychiatric diagnoses
were assessed using the computerized Diagnostic Interview Schedule
version IV (c-DIS-IV) (Robins et al., 1981) using laptop computers.
Cognitive functioning was assessed using 11 test modules (Continuous
Performance Task – Number Letter; Short Letter N-Back Test – 2 Back;
Word Memory Test for Children; Facial Memory Test; Visual Object
Learning Test – Short; Logical Reasoning Test For Children – Short;
Motor Praxis Test; Matrix Analysis Test; List Learning Test; Emotion
Recognition Test for Children – 40 Faces; andMeasured Emotion Differ-
entiation Test) from the University of Pennsylvania Computerized
Neurocognitive Battery (CNB) (Gur et al., 2010). Quantitative measures
of psychosocial stress was assessed using the WERC Stress Screen
(Mamah et al., 2014). The Dyskinesia Identiﬁcation System: Condensed
User Scale (DISCUS) (Kalachnik and Sprague, 1993) was used to rate
items relating to dyskinesia in six upper body regions. Head size was
estimated by measuring the circumference of the head with a cloth
tape measure wrapped around the glabella and the opisthocranion.
2.4. Timeline and schedule of assessments
Participants were evaluated between January 2014 and December
2015. The assessment schedule was baseline, 4-, 7-, 14- and 20-months,
as depicted in Fig. 1. All assessments took place on site in the respective
secondary schools, in conﬁdential spaces within various school meeting
rooms and classrooms.
2.5. Assessing psychosis conversion and progression
Clinical outcome at speciﬁc follow-up assessments was evaluated
using results from the c-DIS-IV and the SIPS. Transition to psychosis
was determined by the presence of a new psychotic diagnosis on the
c-DIS-IV, and/or by meeting psychosis criteria on the SIPS(McGlashan
et al., 2010), i.e. that at least one of the ﬁve SIPS positive symptoms
reached a psychotic level of intensity for a frequency of ≥1 h per day
for 4 days per week during the past month or that symptoms seriously
impacted functioning.
2.6. Statistical analysis
All statistical analyses were done using SAS 9.4 (SAS Institute Inc.,
Cary, NC). Chi-square and two-sided Wilcoxon-Mann-Whitney tests
were used to compare groups on clinical and demographic variables,
considering that many variables did not meet criteria for normality.
Cognitive domains were derived similarly as previously described
Fig. 1. Flowchart depicting selection process and assessment schedule. aPre-selection was done using cutoff scores on the WERCAP Screen, deriving 129 high-risk (scores N 30) and 201
low-risk (scores b 30) participants. Final designation of high-risk status was based on meeting criteria on the WERCAP Screen or SIPS, and exclusion of psychotic subjects. b“Subject
available” refers to those that were available during the baseline assessment period.
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using scores on the psychotic section of theWERCAP Screen, estimated
over the prior 3-months, and the slopes were compared across groups
using the Student's t-test. Stepwise logistic and linear regression were
used to investigate baseline predictors of psychosis conversion or
psychosis severity progression respectively.
3. Results
3.1. Sample characteristics
Demographic data are presented in Table 1. Among HR participants,
119 (i.e. 88.2%) completed at least one follow-up evaluation. 132 (i.e.
93.0%) of the LR participants completed at least one follow-up evalua-
tion. Overall retention rates at 4-, 7-, 12- and 20-months were 79.3%,
77.8%, 53.3% and 49.6% for HR: and 82.4%, 83.8%, 58.5% and 54.2% for LR.
3.2. Clinical characteristics
Table 1 summarizes clinical trait differences across groups. Of theHR
sample, 64 (47.4%) met psychosis-risk criteria on the SIPS, and 105
(78.9%) met risk criteria on the WERCAP. Overall, 34.1% of HR and
11.3% of LR participants had at least one psychiatric comorbidity.
Among the cognitive measures studied, the score on attention was
higher in LR compared to HR participants (Z=−2.2; p= 0.027), how-
ever HR participants scored better on abstraction (Z= 2.4; p = 0.017).
Total stress severity was signiﬁcantly higher in HR than in LR partici-
pants (Z = 5.2; p b 0.0001). Mean severities of individual psychosocial
stressors across groups are shown in Fig. 2. Multiple stressors were
found signiﬁcantly higher in HR compared to LRparticipants, particular-
ly those involving family relationships, death, school and ﬁnances.3.3. Risk traits associated with baseline schizophrenia diagnosis
All variables were investigated as potentially associated with a SZ
diagnosis at baseline in relation to HR participants. A stepwise logistic
regression resulted in only impaired personal hygiene severity being
selected in the ﬁnal model. The results indicated that baseline SZ was
associatedwithmore impaired personal hygiene at baseline thanHR in-
dividuals (estimated OR= 7.4; 95% CI = 1.1, 49.9; B= 2.0, p b 0.0001).
A comparison of clinical proﬁles in SZ vs. HR participants are also shown
in Table 1.3.4. Psychosis conversion and prediction
At 7-months, ﬁve of 131 HR cases (i.e. who had completed c-DIS-IV
or SIPS data) converted to psychosis (3.8%) based on the SIPS, and there
were no further conversion at the 20-month timepoint. None of the
cases met diagnostic criteria for schizophrenia using the c-DIS-IV. In
contrast, there were no LR participants that converted to psychosis.
A comparison of demographic and clinical proﬁles in converters vs.
nonconverters are shown in Table 2. Considering the small number of
converters, we conducted a backward logistic regression including in
the model only the two variables that showed the most signiﬁcant dif-
ferences in univariate analysis (i.e. disorganized communication and
expression of emotions & self, p b 0.01). This analysis showed a signiﬁ-
cant association of conversion only with disorganized communication
(est. OR = 2.43; 95% CI = 1.28, 4.63; B = 0.89, p = 0.007). Results
were identical when logistic regression was conducted using forward
selection to test the stability of the model. Logistic regression was also
conducted using all seven variables that showed signiﬁcant (p b 0.05)
univariate effects. Disorganized communication similarly emerged as
Table 1
Baseline demographic and clinical characteristics across participant groups.
Characteristic LR HR SZ p p
(n = 142) (n = 135) (n = 8) (LR vs. HR) (HR vs. SZ)
Age (SD) 17.1 (1.3) 17.4 (1.3) 17.1 (1.1) 0.12 0.64
Gender (%) 0.64 0.01⁎
Female 84 (59.2) 83 (61.5) 1 (14.3)
Male 58 (40.8) 52 (38.5) 6 (85.7)
Baseline education (%) 0.98 0.36
Grade 10 49 (36.0) 48 (38.1) 2 (28.6)
Grade 11 59 (43.4) 48 (38.1) 2 (28.6)
Grade 12 28 (20.6) 30 (23.8) 3 (42.9)
aHighest maternal education (SD) 9.6 (2.8) 9.8 (3.0) 9.9 (2.3) 0.35 0.95
aHighest paternal education (SD) 9.8 (3.9) 9.8 (3.7) 9.8 (3.0) 0.81 0.23
WERCAP
Psychosis (chronic) 15.9 (11.2) 34.1 (10.7) 28.9 (10.6) b0.0001⁎⁎ 0.07
Psychosis (3-month) 7.9 (9.8) 18.7 (14.5) 24.3 (9.6) b0.0001⁎⁎ 0.15
Affectivity (Chronic) 12.5 (7.8) 21.9 (9.6) 18.5 (9.1) b0.0001⁎⁎ 0.34
Affectivity (3-month) 8.2 (7.5) 15.9 (10.6) 21.6 (4.1) b0.0001⁎⁎ 0.04⁎
SIPS positive symptoms
Unusual thought 0.35 (0.6) 1.37 (1.3) 2.25 (1.8) b0.0001⁎⁎ 0.14
Persecutory 0.27 (0.6) 1.23 (1.3) 1.88 (1.4) b0.0001⁎⁎ 0.15
Grandiosity 0.55 (0.8) 1.26 (1.2) 1.75 (1.7) b0.0001⁎⁎ 0.44
Hallucinations 0.25 (0.6) 1.37 (1.5) 2.63 (1.5) b0.0001⁎⁎ 0.03⁎
Disorg. communication 0.06 (0.3) 0.53 (1.0) 1.50 (1.6) b0.0001⁎⁎ 0.02⁎
SIPS negative symptoms
Social anhedonia 0.30 (0.6) 1.01 (1.6) 1.88 (2.3) b0.0001⁎⁎ 0.33
Avolition 0.14 (0.6) 0.29 (0.8) 1.63 (1.8) 0.03⁎ 0.006⁎
Emotion expression 0.04 (0.2) 0.22 (0.7) 1.25 (1.6) 0.006⁎ 0.001⁎⁎
Emotion/self-experience 0.03 (0.2) 0.23 (0.8) 1.38 (2.0) 0.005⁎ 0.002⁎⁎
Difﬁculty understanding 0.96 (1.3) 1.17 (1.3) 1.50 (1.4) 0.07 0.47
Occupational functioning 0.24 (0.7) 0.51 (1.0) 0.50 (0.5) 0.0048⁎⁎ 0.35
SIPS disorganization symptoms
Odd behavior appearance 0.03 (0.2) 0.20 (0.6) 0.88 (1.5) 0.0006⁎⁎ 0.05
Bizarre thinking 0.01 (0.1) 0.22 (0.7) 0.50 (0.8) 0.0002⁎⁎ 0.047⁎
Trouble focus attention 0.25 (0.5) 0.78 (1.1) 2.00 (1.8) b0.0001⁎⁎ 0.03⁎
Personal hygiene 0.05 (0.2) 0.06 (0.3) 0.88 (1.8) 0.86 0.01⁎
SIPS general symptoms
Sleep disturbance 0.07 (0.0) 0.40 (0.9) 0.63 (1.1) 0.0004⁎⁎ 0.29
Dysphoric mood 0.32 (0.8) 1.24 (0.2) 2.25 (1.8) b0.0001⁎⁎ 0.07
Motor disturbances 0.01 (0.1) 0.18 (0.6) 0 0.002⁎⁎ 0.34
Stress tolerance 0.06 (0.3) 0.30 (0.7) 1.50 (1.7) b0.0001⁎⁎ 0.0006⁎⁎
Diagnostic comorbidity
Panic attack 3 (2.2) 9 (7.0) 2 (25.0) 0.06 0.07
Agoraphobia 2 (1.5) 14 (10.9) 3 (37.5) 0.001⁎⁎ 0.03⁎
Speciﬁc phobia 5 (3.7) 10 (7.8) 1 (12.5) 0.15 0.63
Social phobia 2 (1.5) 8 (6.2) 2 (25.0) 0.04⁎ 0.047⁎
Generalized anxiety 0 4 (3.1) 0 0.04⁎ 0.61
PTSD 1 (0.7) 11 (8.5) 0 0.002⁎⁎ 0.39
Depression 4 (2.9) 12 (9.3) 2 (25.0) 0.03⁎ 0.15
Bipolar disorder 0 9 (8.3) 0 0.002⁎⁎ 0.43
Obsessive compulsive 0 3 (3.3) 1 (12.5) 0.07 0.10
Eating disorder 1 (0.7) 3 (2.3) 0 0.29 0.66
ADHD 1 (0.7) 4 (3.1) 1 (12.5) 0.15 0.17
ODD 4 (2.9) 22 (17.1) 4 (50.0) 0.0001⁎⁎ 0.02⁎
ASPD/conduct 5 (3.7) 16 (12.4) 3 (37.5) 0.008⁎ 0.046⁎
Tobacco 2 (1.5) 1 (0.8) 0 0.60 0.80
Alcohol 1 (0.7) 7 (5.4) 2 (25.0) 0.03⁎ 0.03⁎
Drugs 2 (1.5) 3 (2.3) 1 (12.5) 0.60 0.10
Pathological gambling 0 8 (6.2) 1 (12.5) 0.003⁎ 0.49
Cognitive functioning (z-score)
Abstraction −0.15 (0.9) 0.17 (1.1) −0.07 (1.2) 0.02⁎ 0.57
Attention 0.14 (0.9) −0.13 (1.0) 0.04 (1.5) 0.03⁎ 0.29
Working memory 0.04 (1.0) −0.06 (1.0) 0.16 (0.7) 0.42 0.86
Verbal memory 0.06 (1.0) −0.06 (1.0) −0.12 (0.9) 0.36 0.71
Visual memory 0.02 (1.0) −0.01 (1.0) −0.10 (1.5) 0.86 0.57
Language & reasoning 0.01 (0.9) −0.00 (1.1) 0.07 (1.6) 0.98 0.98
Sensorimotor −0.16 (1.1) 0.14 (0.9) 0.41 (1.6) 0.07 0.34
Emotional cognition −0.11 (0.9) 0.10 (0.8) 0.08 (0.9) 0.11 0.97
(continued on next page)
343D. Mamah et al. / Schizophrenia Research 176 (2016) 340–348
Table 1 (continued)
Characteristic LR HR SZ p p
(n = 142) (n = 135) (n = 8) (LR vs. HR) (HR vs. SZ)
Stress 21.93 (21.2) 38.12 (29.6) 43.38 (26.0) b0.0001⁎⁎ 0.42
Dyskinesia 3.17 (2.8) 3.58 (3.1) 4.25 (3.8) 0.35 0.68
Head circumference 55.3 (1.8) 55.7 (1.9) 55.6 (1.8) 0.07 0.87
Values are given as means (SD) or number per group (%). Results derived from results of two-sided Wilcoxon-Mann-Whitney tests or Chi-Square analyses.
a Education indicated as years of schooling.
⁎⁎ p b 0.005.
⁎ p b 0.05.
344 D. Mamah et al. / Schizophrenia Research 176 (2016) 340–348the only signiﬁcant predictor, using either forward and backward
selection.
3.5. Psychotic symptom severity progression and prediction
In bothHR and LR groups,mean psychotic symptoms improved over
the 20-month study period (Fig. 3). The mean (SD) psychotic symptom
slopewas−0.022 (0.06) in HR and−0.013 (0.02) in LR, without signif-
icant differences (F= 2.3; p= 0.13). A post-hoc investigation of the re-
lationship of the psychotic symptom slope in HR subjects showed a
direct correlation with the affective symptom slope (R = 0.82;
p b 0.0001) and with the stress slope (R = 0.76; p b 0.0001). A similar
relationship was also seen in LR subjects for both the affective (R =
0.31; p = 0.0008) and stress (R = 0.56; p b 0.0001) slopes.
A stepwise multiple regression identiﬁed a subset of 11 explanatory
variables as being important in predicting the slope of psychosis sever-
ity change, and these accounted for 74.4% of the variance. The majority
of the variance (24.7%) of the psychotic symptom slope was associated
with an ADHD diagnosis (B= 0.16; p b 0.0001). A minor positive asso-
ciation with the psychosis symptom slope was also seen with a diagno-
sis of major depression (B = 0.05) and bipolar disorder (B = 0.11),
occupational functioning (B = 0.01), and avolition (B = 0.02). Minor
negative associations were found with a diagnosis of an eating disorder
(B =−0.09), generalized anxiety disorder (B =−0.06), and alcoholFig. 2. Psychosocial stress scores across groups. The ﬁgure shows group mean scores of each st
differences, derived from Students' t-tests of high-risk and low-risk participants only.use disorder (B =−0.01). Results of the stepwise procedure are sum-
marized in Table 3.
4. Discussion
Our current study is the most elaborate investigation of the psycho-
sis-risk state in an African population. We found that there were three
times asmanyHR as LR adolescentswith at least one psychiatric comor-
bidity, and the rate of almost every disorderwas higher in theHR group.
The association of psychiatric disorders with psychotic-like experiences
have been reported in other global populations (Lim et al., 2015). Addi-
tionally, the majority of HR offspring of those with schizophrenia often
have one or more lifetime diagnoses of major psychiatric disorders
(Keshavan et al., 2008). It was notable that among the comorbidities
found in our HR adolescents, the externalizing disorders, ODD and con-
duct disorder, had the highest prevalence. Similar reports have been
previously reported in other psychosis-risk populations (Keshavan et
al., 2008). Analyzing data from the NIMH Catchment Area Project, a
childhood conduct disorder history was also found to be at increased
prevalence in adults with schizophrenia and other major psychiatric
disorders (Robins and Price, 1991).
The schizophrenia prodrome is often associated with increasing
psychosocial stress preceding disorder onset. Our studies found that
psychosocial stressors are reported at greater severity in HR comparedress item obtained from the WERC Stress Screen. Asterisks indicate statistically signiﬁcant
Table 2
Baseline characteristics of HR converters and HR nonconverters.
Characteristic HR converters
(n = 5)
HR nonconverters
(n = 95)
Z/χ2 p
Age (SD) 17.6 (2.1) 17.5 (1.2) −0.29 0.77
Gender (%) 3.86 0.05
Female 1 (20.0) 60 (63.8)
Male 4 (80.0) 34 (36.2)
WERCAP
Psychosis (chronic) 30.2 (4.1) 34.6 (9.6) −1.45 0.15
Psychosis (3-month) 33.2 (18.3) 17.4 (14.9) 2.01 0.04⁎
Affectivity (chronic) 20.0 (12.3) 21.4 (8.6) −0.14 0.89
Affectivity (3-month) 26.4 (11.4) 15.2 (11.3) 2.11 0.04⁎
SIPS positive symptoms
Unusual thought 2.00 (1.6) 1.33 (1.3) 1.04 0.30
Persecutory 1.20 (1.3) 1.25 (1.3) −0.04 0.97
Grandiosity 1.40 (1.3) 1.25 (1.2) 0.22 0.82
Hallucinations 2.60 (1.5) 1.25 (1.5) 1.73 0.08
Disorg. communication 1.80 (1.6) 0.36 (0.8) 2.49 0.01⁎
SIPS negative symptoms
Social anhedonia 2.80 (2.6) 0.89 (1.5) 1.66 0.10
Avolition 0.80 (1.1) 0.22 (0.7) 1.72 0.09
Emotion expression 0.40 (0.9) 0.22 (0.7) 0.50 0.61
Emotion/self experience 1.00 (1.7) 0.18 (0.73) 2.45 0.01⁎
Difﬁculty understanding 0.80 (0.4) 1.19 (1.3) −0.29 0.77
Occupational functioning 0 0.52 (1.0) −1.33 0.18
SIPS disorganization symptoms
Odd behavior appearance 0.20 (0.4) 0.20 (0.6) 0.33 0.74
Bizarre thinking 0.20 (0.4) 0.27 (0.8) 0.32 0.75
Trouble focus attention 0.20 (0.4) 0.85 (1.2) −1.20 0.23
Personal hygiene 0 0.05 (0.3) −0.37 0.71
SIPS general symptoms
Sleep disturbance 2.00 (1.6) 1.33 (1.3) 1.28 0.20
Dysphoric mood 1.20 (1.3) 1.11 (1.7) 0.61 0.54
Motor disturbances 0.40 (0.5) 0.11 (0.4) 2.34 0.02⁎
Stress tolerance 0.60 (0.9) 0.32 (0.7) 0.93 0.35
Diagnostic comorbidity
Panic attack 0 7 (7.6) 0.41 0.52
Agoraphobia 1 (20.0) 10 (10.9) 0.39 0.53
Speciﬁc phobia 1 (20.0) 3 (3.3) 3.36 0.07
Social phobia 0 5 (5.4) 0.29 0.59
Generalized anxiety 0 3 (3.3) 0.17 0.68
PTSD 0 10 (10.9) 0.61 0.44
Depression 0 8 (8.7) 0.47 0.49
Bipolar disorder 0 6 (7.6) 0.25 0.62
Obsessive compulsive 0 3 (3.3) 0.17 0.68
Eating disorder 1 (20.0) 2 (2.2) 5.03 0.02⁎
ADHD 1 (20.0) 2 (2.2) 5.03 0.02⁎
ODD 0 19 (20.1) 1.28 0.26
ASPD/conduct 1 (20.0) 11 (12.0) 0.28 0.59
Tobacco 0 1 (1.1) 0.05 0.81
Alcohol 0 6 (6.5) 0.35 0.56
Drugs 0 2 (2.2) 0.11 0.74
Pathological gambling 1 (20.0) 3 (3.3) 3.36 0.07
Cognitive functioning (z-score)
Abstraction 0.29 (1.3) 0.24 (1.1) 0.08 0.93
Attention −0.69 (1.2) −0.01 (1.0) −1.47 0.14
Working memory 0.11 (1.2) −0.01 (1.0) 0.61 0.54
Verbal memory −0.59 (1.4) −0.07 (1.0) −0.96 0.34
Visual memory −0.71 (1.0) −0.02 (1.0) −1.39 0.16
Language & reasoning −0.08 (1.2) 0.07 (1.1) −0.37 0.71
Sensorimotor −0.14 (1.2) 0.15 (0.8) −0.44 0.66
Emotional cognition −0.03 (1.0) 0.12 (0.8) −0.72 0.47
Stress 49.4 (53.7) 37.5 (29.4) 0.19 0.85
Dyskinesia 3.20 (3.0) 3.60 (3.3) −0.26 0.79
Head circumference 55.90 (1.3) 55.62 (2.0) 0.30 0.76
Values are given as means (SD) or number per group (%). Results derived from results of
two-sided Wilcoxon-Mann-Whitney tests or Chi-Square analyses.
⁎ p b 0.05.
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differences resulted from an increased stress burden in HR adolescents,
or rather from an increased perception of stress severity. Increased
stress reported across multiple items in most HR participants supports
the latter concept. Psychosis liability and pre-existing psychotic experi-
ences have been previously associated with heightened sensitivity to
environmental social stress (Veling et al., 2016). In the NAPLS study,
higher baseline cortisol levels were also seen in those who transitioned
to psychosis compared to remitters and healthy controls (Walker et al.,
2013). Underlying increased stress sensitivity appears to be a hypotha-
lamic-pituitary-axis (HPA) dysfunction, as elevated resting cortisol
levels are often found in psychosis-risk subjects (Aiello et al., 2012;
Carol and Mittal, 2015). Increased sensitivity to stress is known to play
an important role in the transitioning to ﬁrst episode psychosis (Aiello
et al., 2012), thus markers of stress sensitivity such as cortisol levels
and behavioral measures like those used in our current study, may be
promising in illness prediction.
In our study, HR participants showed a unique pattern of cognitive
functioning compared to LR individuals, with worse performance in
attention and higher functioning in abstraction. This may represent a
unique cognitive proﬁle associated with subthreshold psychotic experi-
ences in Kenya. Cognitive deﬁcits are often reported in those at high risk
for psychosis, although generalization of ﬁndings is difﬁcult owing to
the diversity of cognitive assessments methods used (de Paula et al.,
2015). In the NAPLS study, tests of processing speed and verbal learning
and memory were most signiﬁcant in discriminating HR from controls,
however cognitive functioning was not found to contribute uniquely to
prediction of psychosis conversion (Seidman et al., 2010). In general,
improved cognitive performance in psychotic disorders has not been
described, although improved task performance as a result of aberrant
brain connectivity has been reported (Barch et al., 2012; Dima et al.,
2009).
Our longitudinal observations showed that 3.8% of HR subjects
converted to psychosis while none of the LR participants did. These
conversion rates are substantially less than those observed in other
global populations, with previously reported rates of 16–54% after 1–
2.5 years (Cannon et al., 2008; Ruhrmann et al., 2010; Yung et al.,
2008). A few factors may account for this discrepancy across studies.
Firstly, the secondary school students investigated may not have been
a cohort in whom signiﬁcant deterioration would be present at high
rates. The majority of patients with schizophrenia transition post-ado-
lescence, with a peak age of schizophrenia onset in the early to mid
20's for males and in the late 20's for females (APA, 2013). Thus, it
would be likely that most psychosis conversions would occur subse-
quent to our study time frame (Schultze-Lutter et al., 2015). Prodromal
studies done in other countries where higher conversion rates have
been reported generally include older populations. For example in the
ﬁrst NAPLS study (Cannon et al., 2008), the mean age of HR participants
was about a year older than our Kenyan cohort, while other studies had
two years or highermean ages than in our study (Addington et al., 2015;
Yung et al., 2004). Longer follow-up periods in the future, ideally span-
ning the second decade of life, would therefore be important to more
accurately capture conversion rates. Secondly, the outcome of those
with signiﬁcant psychotic experiences in Kenya may be intrinsically
more favorable than those in some other populations, in line with
disparities in some disorder outcomes globally. The course of schizo-
phrenia, for example, has been reported to be less severe in Africa and
other developing countries compared to industrialized countries
(Hopper andWanderling, 2000; Sartorius et al., 1986). Thus it is plausi-
ble that psychotic symptoms would tend to also progress more favor-
ably in these developing countries. Lastly, there was a substantial drop
out by study completion, which could have led to the more severely
affected HR cases being disproportionately lost, leading to an underesti-
mation of conversion rates. These drop out rates however were compa-
rable to those reported in the largest North American prodromal study
to date (Addington et al., 2015), although earlier studies have found
Fig. 3. Progression of psychotic symptom severity in high-risk and low-risk participants. Psychotic symptom severity was assessed using the psychotic section of the WERCAP Screen,
speciﬁed to reﬂect symptoms experienced over the preceding 3 months.
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missed school days, or apprehension associatedwith research participa-
tion could have selectively affected converted cases, and resulted in an
underestimation of our conversion rates. However, most of the drop-
outs by the ﬁnal time point were related to school graduation in the
older students, and there was no increased psychopathology in those
lost to follow-up.
Results from a logistic regression identiﬁed only disorganized
communication as associated with psychosis conversion. Interestingly,
disorganized communication at baseline has also been found by other
groups to predict psychosis onset in HR individuals (Bearden et al.,
2011; DeVylder et al., 2014). Similar to the study by DeVylder et al.
(2014), conducted in North America, other than disorganized commu-
nication, we found no other positive or negative symptoms predictive
of psychosis onset. Clinically, disorganized speech is generally consid-
ered to be reﬂective of an underlying thought disorder, and can involve
a variety of manifestations including derailment, poverty of speech,
tangentiality, perseveration, neologism or thought blocking. Previous
studies have found that unlike some other behavioral symptoms,
clinically relevant thought disorder present at ascertainment tended
to persist and eventually lead to psychosis onset (DeVylder et al.,
2014). These data support the concept of disorganized communication
as a potential endophenotype or stable trait marker for schizophrenia
risk, consistent with the ﬁnding that disorganized communication
aggregates in family members of individuals with schizophrenia (LevyTable 3
Variables identiﬁed by stepwise logistic regression analysis as predicting psychosis sever-
ity progression.
Independent variables R2 Coefﬁcient Std error F value p value
ADHD 0.247 0.159 0.003 20.32 b0.0001
Bipolar I disorder 0.091 0.105 0.002 8.33 0.0054
Occupational functioning 0.067 0.010 0.004 6.69 0.012
pWERCAP (3-month) 0.092 −0.001 0.000 10.72 0.002
Emotion differentiation 0.037 −0.013 0.005 4.56 0.037
Major depression 0.033 0.049 0.002 4.29 0.043
Eating disorder 0.039 −0.092 0.003 5.46 0.023
Avolition 0.033 0.023 0.007 4.96 0.03
Alcohol use disorder 0.041 −0.009 0.003 6.76 0.012
Odd behavior/appearance 0.042 −0.029 0.010 7.83 0.007
Generalized anxiety disorder 0.026 −0.059 0.003 5.21 0.027
Total variance (R2) = 74.4%. Model F(11,63) = 13.75; p b 0.0001; Intercept =−0.0026.et al., 2010) and predicts psychosis onset also in genetic HR individuals
(Ott et al., 2002). While disorganized speech and thought disorder may
be a useful marker for psychosis development risk, it is important to
note that thought disorder is not unique to psychotic disorders, and
may also be a symptom of other conditions, including mania. Although
we did not identify other behavioral features predicting psychosis risk,
future longer duration studies may reveal additional predictive risk
traits. Some of these may involve traits found to be more severe in the
small number of schizophrenia patients in our study, compared to our
HR participants. Most notable among these were negative symptoms,
impaired personal hygiene and impaired stress tolerance. Disorganized
communication, accompanied by negative symptoms and impaired
personal hygiene could therefore potentially be behavioral features
that may warrant closer monitoring in Kenyan adolescent populations.
Unlike results from Northern American (Addington et al., 2015;
Cannon et al., 2008) or Australian (Thompson et al., 2011; Yung et al.,
2004) studies, we did not ﬁnd other traits such as unusual thought con-
tent, paranoia, low social functioning, substance abuse or familial risk
with functional decline, as predictors of psychosis conversion. This
may partly have been due to the younger cohort in our studies and in-
adequate time to conversion, as described above. Substance use was
also very rare among our HR cohorts, thus would be unlikely to show
up as a predictor. Familial risk was not applicable to our study as none
of our participants reported a family history of psychotic disorders. In
Kenya, as in many other developing countries, psychiatric disorders
are diagnosed at relatively low rates and for many youths, there is an
unfamiliarity with diagnostic entities (Mamah et al., 2013b). This
underscores the need for increased mental health education in Africa,
particularly in rural communities.
A unique approach to risk analysis in our studies involved the inves-
tigation of changes in psychotic symptom severity. This approach ac-
knowledges that clinical outcomes not meeting a diagnostic threshold
for a psychotic disorder like schizophrenia, may also be signiﬁcantly
disabling. Results of our cross-sectional studies, showing increased co-
morbidity, stress, negative symptoms, disorganization and general
symptoms in HR individuals, further conﬁrms that overall disability
and functioning is associated with high psychotic symptomatology
despite an absence of a psychotic disorder diagnosis. Statistically, inves-
tigating a range of psychotic severity outcomes would also have more
power to identify risk factors in regression analysis. Our ﬁndings
showed decreased psychotic symptom severity over the course of the
347D. Mamah et al. / Schizophrenia Research 176 (2016) 340–348study period in HR participants, as well as in LR participants. Improving
psychotic symptomatology in longitudinal studies has been reported by
other groups, and it has been speculated that this may represent the
natural course of psychotic symptomatology in HR individuals
(Addington et al., 2015; Lee et al., 2014). In our study, there were no
known unique external events, which may have contributed to symp-
tom improvement. It is plausible that participant interactions with the
research team members during the course of the study may have
inadvertently led to a “therapeutic” symptom reduction. Some evidence
to this presumption is the observation of gradually decreasing stress
levels alongside psychotic symptom improvement. Participants, who
previously had little or no exposure to mental health care, may have di-
rectly beneﬁted by talking about their symptoms and receiving
psychoeducation, support and/or information about treatment options
during the course of the study.While themajority of ourHRparticipants
showed improvement in psychotic symptom severity, a multiple re-
gression analysis showed that some factors were associated with less
improvement, including a baseline diagnosis of ADHD, bipolar disorder
andmajor depression. Pre-illness, non-speciﬁc affective symptomatolo-
gy has been suggested as useful in the prediction of schizophrenia and
related psychotic disorders (Owens and Johnstone, 2006), and relatively
high rates of ADHD have been reported in familial psychosis-risk popu-
lations, suggesting that a liability of this disorder might be mediated by
genetic factors that might overlapwith the susceptibility to schizophre-
nia (Keshavan et al., 2008). Interestingly, having a baseline diagnosis of
an eating disorder, generalized anxiety disorder and alcohol use
disorder were associated with greater psychosis improvement, which
indicates that the presence of these disordersmay bemarkers of under-
lying pathology that is unrelated to an impending psychotic disorder
development. Poor occupational functioning and avolition were also
among the factors associatedwith less psychosis severity improvement,
implying that impaired functioning at baseline may also help predict
clinical outcomes in HR individuals.
As our study only had a limited number of psychotic conversions, a
larger cohort of Kenyan adolescents would be required to validate our
risk prediction results. More importantly, future studies would beneﬁt
by investigating HR populations for longer time periods to identify
other potential markers of risk as conversion continues to occur at
older ages. Assessments could be conducted in tertiary institutions or
community settings during early adulthood, when the ﬁrst episode of
a psychotic disorder usually occurs. Incorporation of biological mea-
sures as potential risk markers such as DNA or neuroimaging data,
may also be helpful for identifying those at the greatest risk for psycho-
sis. Such studies would require signiﬁcant investment in mental health
research in Africa, but would likely yield substantial beneﬁts in the pre-
vention of debilitating psychotic disorders such as schizophrenia.
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